Results for ebitda

$BNTX seems to be bottoming in the major monthly support area again. Currently trading at a EV/S of 0.9x and EV/EBITDA of just 1.4x Over $20 billion in cash. Covid earnings will be weakining and thats why a successful development of the huge pipeline is pivotal for the future.

$CLVLY multiples finally cooling off a bit making Clinuvel highly attractive again with stellar revenue, EBITDA and income numbers and development. Cash steadily increasing with no noteworthy debt. Unknown australian high quality name.

$CANO $CMAX $PRVA $AGL $HUM $UNH $ELV The things we took away from $CMAX investor day that impact everyone: 1. They showed the imbedded revenue of the current patient panel AND a slide showing the EBITDA potential at maturity of everyone today and what they expect to have in…

Yü Group #YU . announces final results for the year ended 31 December 2022. Highlights include: ✅Revenue of £278.6m (+79%) ✅Adjusted EBITDA up 359% to £7.9m ✅Profit before tax up 72% to £5.8m More info:

Stocks In News | JK Lakshmi Cement management meet takeaways The company targets improving EBITDA/tn by Rs 300 to Rs 1000/tn How does it plan to achieve its target? @vamakshidhoria  explains the companies' plans and goals #StockMarket  @JKLCofficial  #JKLakshmi 

$APEMY $APMSF - Aperam: Trading At A 12% FCF Yield Despite A 47% Lower EBITDAAssumption. #business  #stockmarket  #markets 

$EPAM now @ ~13x '24 EV/EBIT. NTM multiple near 11 year lows (~15x). Not bad place to look when EBITDA growth estimates next 2 years are +20% CAGR.

Redeye provides an update on Zordix following its Q4 2022 report. Revenue came in slightly above our forecasts, whereas EBITDA was lower than expected. We trim our EBITDA estimate and lower our valuation: $ZORDIX

(2/n) Fundamentals ▪MktCap - 8400cr ▪Book Value - 546 ▪Debt Free ▪P/S - 0.79x ▪P/E - 4.7x ▪P/B - 0.99x ▪ROE - 24.5% ▪ROCE - 33.1% 👉Co has 1370 cr Cash in hand which is ~16.5% of Mkt cap ⚡️Trades at just 2.6x EV/EBITDA

PPC expects EBITDA to jump 30% after takeover